HAVN Life Sciences Inc. Stock Analysis HAVN.CN

HAVN Life Sciences, Inc. is a biotechnology company, which provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions. The firm is focused on standardizing the extraction of psychoactive compounds, the development of natural health products, and developing mental health treatments to support brain health and enhance the capabilities of the mind. HAVN Labs is engaged in the development of its first psilocybin grow in Jamaica and will operate from its research facility in Vancouver. HAVN Labs will provide standardized psychedelic compound formulations for academic institutions with isolates and extractions from its facility that will be utilized for clinical trials and as active pharmaceutical ingredients for products. HAVN Retail is engaged in the expansion of distribution channels. Its products include Bacopa Brain, Reishi Recharge, Cordyceps Perform, Lion's Mane, Rhodiola Relief, among others. The company offers a full range of mushroom and plant extracts that help boost immune function, reduce inflammation, and support a healthy lifestyle.